Thursday's Small-Cap Winners & Losers
Praecis Pharmaceuticals (PRCS) enjoyed a stratospheric surge after pharmaceutical giant GlaxoSmithKline (GSK) agreed to buy it for $5 a share, or about $54.8 million. The buyout price represents a premium of about 150% over Massachusetts-based Praecis's $2 closing price Wednesday. The companies expect the transaction to close in the first quarter of 2007. Praecis shares were trading up $2.90, or 145%, to $4.90. GlaxoSmithKline shares, meanwhile, were edging down 40 cents, or 0.8%, to $51.89.
Coastal Financial (CFCP) shot up on news that it would be bought by fellow Southeastern bank BB&T (BBT). The deal is valued at $394.6 million, or $17.04 a Coastal share. Coastal, based in Myrtle-Beach, S.C., says the transaction will close in the second quarter. Its shares were gaining $2.22, or 15.4%, to $16.66. BB&T shares were dipping 6 cents, or 0.1%, to $44.21.
Horizon Health (HORC) shares also ballooned on merger news. The Lewisville, Texas-based health care provider will be sold to Tennessee's Psychiatric Solutions (PSYS) for about $426 million. The acquisition values each Horizon share at $20. The transaction is expected to close in the second quarter. Horizon was adding $3.20, or 19.8%, to $19.33. Psychiatric was up $1.43, or 4%, to $37.51.
Web service provider Onstream Media (ONSM) soared after it announced a sweeping upgrade of its automation and video-search capabilities. The Pompano Beach, Fla.-based company said its technology now easily interfaces with social networking sites and video advertising, and that it allows customers to easily publish videos to the Internet in various formats. New video processing capabilities can also convert speech within videos to text, allowing for more efficient and accurate searches. Shares were up $1.16, or 54.7%, to $3.28.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV